Reduction of Bacterial Burden and Pain in Chronic Wounds Using a New Polyhexamethylene Biguanide Antimicrobial Foam Dressing-Clinical Trial Results
Authors:
- R. Gary SibbaldRSR. Gary Sibbald
- Patricia CouttsPCPatricia Coutts
- Kevin Y. WooKWKevin Y. Woo
- 1 February 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Advances in Skin & Wound Care
- Vol. 24 (2) , 78-84
Abstract
A randomized controlled trial to evaluate the effectiveness of a polyhexamethylene biguanide (PHMB) foam dressing compared with a similar non-antimicrobial foam for the treatment of superficial bacterial burden, wound-associated pain, and reduction in wound size. This study was conducted in 2 wound healing clinics-a university hospital-based clinic and a community-based clinic. Forty-five chronic wound subjects, stratified to either foot or leg ulcers, were followed for 5 weeks. A multicenter, prospective, double-blind, pilot, randomized controlled clinical trial with 3 study visits (Weeks 0, 2, 4) documented pain and local wound characteristics using NERDS and STONEES clinical criteria to determine superficial bacterial damage or deep/surrounding infection. The use of PHMB foam dressing was a significant predictor of reduced wound superficial bacterial burden (P = .016) at week 4 as compared with the foam alone. Pain reduction was also statistically significant at week 2 (P = .0006) and at week 4 (P = .02) in favor of the PHMB foam dressings. Polymicrobial organisms were recovered at week 4 in 5.3% in the PHMB foam dressing group versus 33% in the control group (P = .04). Subjects randomized to the PHMB foam dressing had a 35% median reduction in wound size by week 4, compared with 28% in the control group. PHMB foam dressing successfully reduced chronic wound pain and bacterial burden.Keywords
This publication has 13 references indexed in Scilit:
- Minimising wound‐related pain at dressing change: evidence‐informed practiceInternational Wound Journal, 2008
- The Edge EffectAdvances in Skin & Wound Care, 2007
- Bacterial decontamination of surgical wounds treated with Lavasept®International Journal of Hygiene and Environmental Health, 2006
- Increased Bacterial Burden and InfectionAdvances in Skin & Wound Care, 2006
- Health-Related Quality of Life in Diabetic Patients With Foot UlcersJournal of Wound, Ostomy & Continence Nursing, 2005
- Pathophysiology of Chronic Nonhealing WoundsJournal of Burn Care & Rehabilitation, 2005
- Preventing Foot Ulcers in Patients With DiabetesJAMA, 2005
- Pseudomonas aeruginosa-induced infection and degradation of human wound fluid and skin proteins ex vivo are eradicated by a synthetic cationic polymerJournal of Antimicrobial Chemotherapy, 2004
- Cost of managing complications resulting from type 2 diabetes mellitus in CanadaBMC Health Services Research, 2003
- Multicenter Study of the Incidence of and Predictive Risk Factors for Diabetic Neuropathic Foot UlcerationDiabetes Care, 1998